Standard BioTools Price to Book Ratio 2010-2023 | LAB
Historical price to book ratio values for Standard BioTools (LAB) over the last 10 years. The current price to book ratio for Standard BioTools as of May 09, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Standard BioTools Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-05-09 | 2.41 | 1.18 | |
| 2023-12-31 | 2.21 | $2.03 | 1.09 |
| 2023-09-30 | 2.90 | $2.26 | 1.28 |
| 2023-06-30 | 1.93 | $2.50 | 0.77 |
| 2023-03-31 | 1.95 | $2.72 | 0.72 |
| 2022-12-31 | 1.17 | $2.89 | 0.40 |
| 2022-09-30 | 1.10 | $3.14 | 0.35 |
| 2022-06-30 | 1.60 | $3.48 | 0.46 |
| 2022-03-31 | 3.59 | $0.29 | 12.53 |
| 2021-12-31 | 3.92 | $1.23 | 3.19 |
| 2021-09-30 | 6.59 | $1.30 | 5.07 |
| 2021-06-30 | 6.16 | $1.44 | 4.29 |
| 2021-03-31 | 4.52 | $1.64 | 2.76 |
| 2020-12-31 | 6.00 | $1.87 | 3.22 |
| 2020-09-30 | 7.43 | $2.05 | 3.62 |
| 2020-06-30 | 4.01 | $1.86 | 2.15 |
| 2020-03-31 | 2.54 | $2.00 | 1.27 |
| 2019-12-31 | 3.48 | $2.20 | 1.58 |
| 2019-09-30 | 4.63 | $2.34 | 1.98 |
| 2019-06-30 | 12.32 | $2.49 | 4.95 |
| 2019-03-31 | 13.29 | $2.64 | 5.03 |
| 2018-12-31 | 8.62 | $1.46 | 5.90 |
| 2018-09-30 | 7.49 | $0.57 | 13.14 |
| 2018-06-30 | 5.96 | $0.89 | 6.70 |
| 2018-03-31 | 5.84 | $1.25 | 4.68 |
| 2017-12-31 | 5.89 | $0.80 | 7.38 |
| 2017-09-30 | 5.04 | $1.01 | 4.98 |
| 2017-06-30 | 4.04 | $0.81 | 4.96 |
| 2017-03-31 | 5.69 | $1.31 | 4.33 |
| 2016-12-31 | 7.28 | $1.82 | 3.99 |
| 2016-09-30 | 8.01 | $2.33 | 3.43 |
| 2016-06-30 | 9.03 | $2.90 | 3.11 |
| 2016-03-31 | 8.07 | $3.43 | 2.36 |
| 2015-12-31 | 10.81 | $3.98 | 2.71 |
| 2015-09-30 | 8.11 | $4.31 | 1.88 |
| 2015-06-30 | 24.20 | $4.61 | 5.25 |
| 2015-03-31 | 42.10 | $4.96 | 8.49 |
| 2014-12-31 | 33.73 | $5.31 | 6.36 |
| 2014-09-30 | 24.50 | $5.47 | 4.48 |
| 2014-06-30 | 29.40 | $5.75 | 5.12 |
| 2014-03-31 | 44.07 | $5.98 | 7.37 |
| 2013-12-31 | 38.28 | $3.74 | 10.25 |
| 2013-09-30 | 21.94 | $3.79 | 5.79 |
| 2013-06-30 | 17.46 | $3.86 | 4.52 |
| 2013-03-31 | 18.51 | $3.94 | 4.70 |
| 2012-12-31 | 14.31 | $4.01 | 3.57 |
| 2012-09-30 | 17.00 | $4.11 | 4.14 |
| 2012-06-30 | 15.04 | $2.37 | 6.34 |
| 2012-03-31 | 15.73 | $2.53 | 6.21 |
| 2011-12-31 | 13.16 | $2.80 | 4.70 |
| 2011-09-30 | 13.93 | $2.92 | 4.76 |
| 2011-06-30 | 16.77 | $3.12 | 5.38 |
| 2011-03-31 | 14.31 | $3.50 | 4.09 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.650B | $0.106B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.024B | 20.33 |
| Inspire Medical Systems (INSP) | United States | $4.855B | 0.00 |
| Axonics (AXNX) | United States | $3.435B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.072B | 0.00 |
| 10x Genomics (TXG) | United States | $3.022B | 0.00 |
| Azenta (AZTA) | United States | $3.015B | 163.85 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.918B | 0.00 |
| Enovis (ENOV) | United States | $2.779B | 20.60 |
| Hims & Hers Health (HIMS) | United States | $2.603B | 0.00 |
| Privia Health (PRVA) | United States | $2.238B | 99.26 |
| Schrodinger (SDGR) | United States | $1.679B | 0.00 |
| Omnicell (OMCL) | United States | $1.376B | 47.56 |
| Phreesia (PHR) | United States | $1.237B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.636B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
| Talkspace (TALK) | United States | $0.451B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.431B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.393B | 0.00 |
| Pulmonx (LUNG) | United States | $0.342B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.300B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.236B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.201B | 0.00 |
| American Well (AMWL) | United States | $0.150B | 0.00 |
| Augmedix (AUGX) | United States | $0.128B | 0.00 |
| TruBridge (TBRG) | United States | $0.121B | 5.17 |
| MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
| 111 (YI) | China | $0.094B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.079B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.049B | 0.00 |
| Movano (MOVE) | United States | $0.039B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Syra Health (SYRA) | United States | $0.012B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| ETAO (ETAO) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |